.beta.1-Selective adrenoceptor antagonists. 3. 4-Azolyl linked phenoxypropanolamines
- 1 April 1984
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 27 (4) , 503-509
- https://doi.org/10.1021/jm00370a012
Abstract
A series of 4-substituted phenoxypropanolamines was prepared and examined for .beta.-adrenoceptor activity. The 4-substituents, di- and triazole ring systems connected to the phenoxy ring by different length chains, were chosen as a means of introducing cardioselectivity. This was achieved, especially in the 1-[4-[(4-chloropyrazol-1-yl)methoxy]phenoxy]-3-(isopropylamino)-2-propanol (11), the 4-[(2H-1,2,3-triazol-2-yl)methoxy] analog (21) and the 4-[2-(2H-1,2,3-triazol-2-yl)ethoxy] analog (22), which show potent .beta.1-blockade [in rats] with selectivity ratios in excess of 100:1. Structure-activity relationships are discussed, and the optimum position of the heteroatom in the 4-substituent is defined.This publication has 3 references indexed in Scilit:
- .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolaminesJournal of Medicinal Chemistry, 1983
- .beta.1-Selective adrenoceptor antagonists. 1. Synthesis and .beta.-adrenergic blocking activity of a series of binary (aryloxy)propanolaminesJournal of Medicinal Chemistry, 1983
- .beta.1-Selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole classJournal of Medicinal Chemistry, 1983